ACCESSION: MSBNK-SMB_Measured-HSA001P0141006
RECORD_TITLE: Annotated; Metenamine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 70
COMMENT: RAW_SPEC {'BLK01_1614': {'bp': 984716.0, 'sum': 2424437.0}, '9_posi_1741': {'bp': 599027.0, 'sum': 1530622.0}, '6_posi_1673': {'bp': 643902.0, 'sum': 1571078.0}, '7_posi_1630': {'bp': 723084.0, 'sum': 1702264.0}, 'BLK01_1782': {'bp': 972749.0, 'sum': 2481909.0}, '19_posi_1007': {'bp': 241693.0, 'sum': 864752.0}, '4_posi_1803': {'bp': 550580.0, 'sum': 1453715.0}, '8_posi_1801': {'bp': 579427.0, 'sum': 1558573.0}, '16_posi_1715': {'bp': 588037.0, 'sum': 1494144.0}, '7_posi_1715': {'bp': 594724.0, 'sum': 1592945.0}, '3_posi_1739': {'bp': 608273.0, 'sum': 1544065.0}, '15_posi_1763': {'bp': 613213.0, 'sum': 1543792.0}, '1_posi_1691': {'bp': 616476.0, 'sum': 1627441.0}, '16_posi_1634': {'bp': 623106.0, 'sum': 1576692.0}, '1_posi_1763': {'bp': 636080.0, 'sum': 1591039.0}, '19_posi_1802': {'bp': 638458.0, 'sum': 1602730.0}, '10_posi_1782': {'bp': 645141.0, 'sum': 1608039.0}, '4_posi_1633': {'bp': 688764.0, 'sum': 1698311.0}, 'ProcedureBlank_1658': {'bp': 705254.0, 'sum': 1779641.0}, '14_posi_1570': {'bp': 750348.0, 'sum': 1814602.0}, 'ProcedureBlank_1131': {'bp': 340591.0, 'sum': 1209297.0}, '14_posi_1656': {'bp': 582763.0, 'sum': 1534617.0}, '12_posi_1738': {'bp': 594787.0, 'sum': 1570972.0}, '10_posi_1696': {'bp': 611765.0, 'sum': 1570289.0}, '2_posi_1632': {'bp': 619282.0, 'sum': 1641346.0}, '13_posi_1593': {'bp': 632160.0, 'sum': 1578129.0}, '8_posi_1633': {'bp': 638953.0, 'sum': 1695750.0}, '11_posi_1569': {'bp': 700980.0, 'sum': 1739259.0}, '9_posi_1572': {'bp': 739906.0, 'sum': 1805979.0}, '8_posi_1133': {'bp': 317953.0, 'sum': 1117392.0}, '6_posi_1760': {'bp': 545441.0, 'sum': 1385974.0}, '14_posi_1742': {'bp': 551141.0, 'sum': 1463059.0}, '16_posi_1800': {'bp': 575865.0, 'sum': 1543648.0}, '13_posi_1760': {'bp': 576740.0, 'sum': 1474267.0}, '2_posi_1801': {'bp': 583836.0, 'sum': 1556309.0}, '15_posi_1677': {'bp': 586332.0, 'sum': 1508849.0}, '13_posi_1676': {'bp': 598185.0, 'sum': 1522534.0}, '8_posi_1717': {'bp': 604197.0, 'sum': 1589425.0}, '7_posi_1802': {'bp': 607266.0, 'sum': 1622155.0}, '11_posi_1655': {'bp': 611119.0, 'sum': 1567930.0}, '9_posi_1655': {'bp': 645041.0, 'sum': 1653762.0}, 'BLK02_1739': {'bp': 671069.0, 'sum': 1732116.0}, '17_posi_1591': {'bp': 689099.0, 'sum': 1715826.0}, '19_posi_1634': {'bp': 711881.0, 'sum': 1668132.0}, '1_posi_1574': {'bp': 718176.0, 'sum': 1865442.0}, 'ProcedureBlank_1757': {'bp': 738202.0, 'sum': 1769656.0}, '11_posi_1740': {'bp': 533228.0, 'sum': 1410122.0}, '2_posi_1718': {'bp': 560353.0, 'sum': 1502128.0}, '3_posi_1568': {'bp': 689350.0, 'sum': 1750992.0}, '19_posi_1720': {'bp': 707187.0, 'sum': 1708215.0}, '6_posi_1587': {'bp': 769623.0, 'sum': 1843414.0}, '17_posi_1760': {'bp': 580856.0, 'sum': 1509465.0}, '17_posi_1677': {'bp': 608802.0, 'sum': 1586113.0}, '3_posi_1654': {'bp': 630422.0, 'sum': 1664033.0}, '15_posi_1593': {'bp': 658987.0, 'sum': 1662882.0}, '10_posi_1614': {'bp': 685864.0, 'sum': 1732023.0}, '18_posi_1587': {'bp': 746047.0, 'sum': 1747394.0}, '7_posi_1132': {'bp': 320596.0, 'sum': 1125848.0}, '12_posi_1635': {'bp': 611632.0, 'sum': 1585040.0}, 'BLK02_1567': {'bp': 703219.0, 'sum': 1838707.0}, 'BLK01_899': {'bp': 639861.0, 'sum': 2048517.0}, '18_posi_1758': {'bp': 605986.0, 'sum': 1502554.0}, '4_posi_1718': {'bp': 596266.0, 'sum': 1525265.0}, '5_posi_1784': {'bp': 589148.0, 'sum': 1491096.0}, 'ProcedureBlank_1573': {'bp': 736104.0, 'sum': 1758900.0}, '18_posi_1675': {'bp': 706367.0, 'sum': 1645466.0}, '5_posi_1700': {'bp': 619538.0, 'sum': 1584674.0}, 'BLK02_1658': {'bp': 687342.0, 'sum': 1793783.0}, '5_posi_1611': {'bp': 620298.0, 'sum': 1667726.0}, 'BLK01_1699': {'bp': 905096.0, 'sum': 2357567.0}}
COMMENT: RETENTION_TIME_STDEV 0.358
COMMENT: PRECURSOR_M/Z_RAW 141.113144
COMMENT: PRECURSOR_M/Z_STDEV 0.000034
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.100; C6H12N4; [M+H]+; delta(ppm) 0.099924
COMMENT: PROPOSED_MF MS-FINDER 3.128; C6H12N4; [M+H]+; delta(ppm) 0.093228
COMMENT: PROPOSED_MF SIRIUS5_Sirius 43.061; C6H12N4; [M+H]+; delta(ppm) 0.093228
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H12N4; [M+H]+; delta(ppm) 0.093228
COMMENT: PROPOSED_MF SIRIUS6_Sirius 60.811; C6H12N4; [M+H]+; delta(ppm) 0.093228
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.123; C8H14NO; [M+H]+; delta(ppm) -9.421462
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H12N4; [M+H]+; delta(ppm) 0.093228
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 3.000; VKYKSIONXSXAKP-UHFFFAOYSA-N; C6H12N4; Spectral Match to Methenamine from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.375; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; C1N2CN3CN1CN(C2)C3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.185; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; CCCCCC1=NNN=N1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.128; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; Metenamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.867; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; 5-pentyl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; Metenamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.968; OKIYPFZZDQLNMP-UHFFFAOYSA-N; [M+H]+; 5-pentyl-2H-tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.723; VKYKSIONXSXAKP-UHFFFAOYSA-N; [M+H]+; 1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; VCTVUJOTOJYMIS-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; UXVISKUHAHDCFI-UHFFFAOYSA-N; [M+H]+; 2-(1-ethyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; FXQOTTKAHLPLGZ-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)butan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.061; DWLZOAQNIPAAFO-UHFFFAOYSA-N; [M+H]+; 2-(4-ethyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; KYIVZQNAWBHHAT-UHFFFAOYSA-N; [M+H]+; 2-(3-ethyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.045; SGBUUHYQJQZIEF-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-2H-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.043; OIVJDIWINLEWFU-UHFFFAOYSA-N; [M+H]+; 2-(3,5-dimethyl-1,2,4-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; TYWRRCQYQXNVEK-UHFFFAOYSA-N; [M+H]+; 2-(4,5-dimethyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; FXVXCWWBFBEURF-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-1H-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; BUEANCSGTDXMMH-UHFFFAOYSA-N; [M+H]+; 3-(2-methyltriazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; CUTNSFKUMKABGS-UHFFFAOYSA-N; [M+H]+; N'-(2-methylpyrazol-3-yl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; HKIVZMPMDHNWNR-UHFFFAOYSA-N; [M+H]+; 3-(4-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.034; WMLLVXMZSGSSEU-UHFFFAOYSA-N; [M+H]+; 3-(1-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.034; LUXLFSWSHAECCA-UHFFFAOYSA-N; [M+H]+; (1-propyltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; KEMNTRIYSIFNIW-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpyrazol-3-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; UVRLGILFHWSWKE-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-propan-2-yl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; BGISKSHLHYGZFQ-UHFFFAOYSA-N; [M+H]+; 1-tert-butyl-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; MLGQMJALMNGPSR-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yltriazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; JGGUUJRQUZZUIB-UHFFFAOYSA-N; [M+H]+; 2-(4-methyl-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; ZFOZOCLSYJLZPG-UHFFFAOYSA-N; [M+H]+; (1-propan-2-yl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.988; OWZRZTYYKXCIAI-UHFFFAOYSA-N; [M+H]+; (4-propan-2-yl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; FBILVWGTLWCYPU-UHFFFAOYSA-N; [M+H]+; 3-(azidomethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; FRHFXFXZSQDYBC-UHFFFAOYSA-N; [M+H]+; (3-propan-2-yl-1H-1,2,4-triazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.968; IGHVGDCSIUTUFP-UHFFFAOYSA-N; [M+H]+; 4-(azidomethyl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; HIWAIHBATLLXPU-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrazol-4-yl)ethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; MHDCDPXQCUJWCH-UHFFFAOYSA-N; [M+H]+; 2-butyl-1-cyanoguanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; QURWPRWUDYEQNR-NTSWFWBYSA-N; [M+H]+; (1S,2R)-2-azidocyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; YYLBLMYFEQNWIL-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)butan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; PZSRJLZFQGEFSY-RXMQYKEDSA-N; [M+H]+; (2R)-1-(1-methyltriazol-4-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; ODGGHRYHUQOMIE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)butan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; JYXQLWGUUVLZPQ-UHFFFAOYSA-N; [M+H]+; 1-(5-ethyl-1H-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.928; BLFOJPQSVBUXAO-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-2-(1,2,4-triazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; UNPBPOSGHGAKDM-UHFFFAOYSA-N; [M+H]+; 5-(2-methylpropyl)-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; PXEAJKYSDKTUPF-RXMQYKEDSA-N; [M+H]+; (1R)-1-(3-methyltriazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; KWCLNZQGWCJRBO-RXMQYKEDSA-N; [M+H]+; (1R)-1-(5-methyl-1H-1,2,4-triazol-3-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.875; LZTMJFUDZMELMK-UHFFFAOYSA-N; [M+H]+; 2-(5-methyl-1H-1,2,4-triazol-3-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.869; OUEULNVXHMKTKS-UHFFFAOYSA-N; [M+H]+; 5-methyl-1-(2-methylpropyl)tetrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.863; LNIXWHZGFOEORC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(2H-triazol-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.695; FGCGZUFQSOYAJG-UHFFFAOYSA-N; [M+H]+; 5-(2-methylbutan-2-yl)-2H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -19.969; VKYKSIONXSXAKP; [M+H]+; Ammoform
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.996; BLFOJPQSVBUXAO; [M+H]+; 1-(2-Dimethylaminoethyl)-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.007; MHDCDPXQCUJWCH; [M+H]+; 1-Butyl-3-cyanoguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.295; OUEULNVXHMKTKS; [M+H]+; 1-Isobutyl-5-methyl-1H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.305; LOLVREZTZUWBEQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.217; NMHCNWRIEUCNEX; [M+H]+; ACMC-20lgjx
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.322; FGCGZUFQSOYAJG; [M+H]+; 5-(1,1-Dimethylpropyl)-5H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.787; VKYKSIONXSXAKP; [M+H]+; Ammoform
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -39.864; VKYKSIONXSXAKP; [M+H]+; 1,3,5,7-tetraazatricyclo[3.3.1.1³,⁷]decane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -129.565; MHDCDPXQCUJWCH; [M+H]+; Guanidine, 1-butyl-3-cyano-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -180.337; BLFOJPQSVBUXAO; [M+H]+; 1H-1,2,4-Triazole, 1-(2-dimethylaminoethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.096; UVRLGILFHWSWKE; [M+H]+; 1-Isopropyl-5-methyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -198.278; LOLVREZTZUWBEQ; [M+H]+; ethyl[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.226; BGISKSHLHYGZFQ; [M+H]+; 1-(tert-Butyl)-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -222.387; OUEULNVXHMKTKS; [M+H]+; 1-Isobutyl-5-methyl-1H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.316; FRHFXFXZSQDYBC; [M+H]+; [5-(Propan-2-YL)-4H-1,2,4-triazol-3-YL]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -248.077; NMHCNWRIEUCNEX; [M+H]+; 2-Amino-5-methylhistamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -262.131; FGCGZUFQSOYAJG; [M+H]+; 5-(1,1-Dimethylpropyl)-5H-tetrazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.548; VKYKSIONXSXAKP; [M+H]+; 1,3,5,7-tetraazatricyclo[3.3.1.1³,⁷]decane
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Metenamine, VKYKSIONXSXAKP-UHFFFAOYSA-N; Matching to 3 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0029598;
CH$NAME: Metenamine
CH$NAME: 1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H12N4
CH$EXACT_MASS: 140.106196
CH$SMILES: C1N2CN3CN1CN(C2)C3
CH$IUPAC: InChI=1S/C6H12N4/c1-7-2-9-4-8(1)5-10(3-7)6-9/h1-6H2
CH$LINK: CHEBI CHEBI:6824
CH$LINK: HMDB HMDB0029598
CH$LINK: INCHIKEY VKYKSIONXSXAKP-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:4101
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.291
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 141.113486
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-2900000000-12e6f9772aaca5038119
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0651939 17.5140 58.065830 1.6878 3.11 0.6103 70 f{C3H8N1}/1.18ppm,p-C3H5N3
  69.0447344 39.7433 69.045360 0.7531 11.88 0.3913 70 f{C3H5N2}/0.14ppm,p-C3H8N2
  70.0418303 6.7666 70.042450 1.8560 1.78 0.3471 56 ?
  70.0480904 28.0657 70.048710 0.9993 7.45 0.4021 70 ?
  70.0651405 25.9787 70.065760 1.2702 8.05 0.1345 70 f{C4H8N1}/0.21ppm,p-C2H5N3
  71.0603668 53.4316 71.060980 0.6192 10.19 0.5542 70 f{C3H7N2}/-0.11ppm,p-C3H6N2
  72.0444235 33.3082 72.045030 0.8883 9.03 0.3352 70 ?
  73.0477607 20.4209 73.048360 1.6154 5.39 0.4340 70 ?
  85.0760408 121.9063 85.076520 0.4467 9.19 0.8274 70 f{C4H9N2}/0.19ppm,p-C2H4N2
  95.0604701 17.3135 95.060830 2.0724 31.87 0.1710 67 f{C5H7N2}/1.00ppm,p-C1H6N2
  97.0760750 8.8107 97.076420 2.0808 3.04 0.0760 59 f{C5H9N2}/0.52ppm,p-C1H4N2
  98.0713127 97.7909 98.071650 0.4487 8.02 0.7974 70 f{C4H8N3}/0.40ppm,p-C2H5N1
  100.0758189 14.6865 100.076140 2.1184 5.30 -0.2037 70 ?
  107.0604376 9.4879 107.060695 2.4099 4.22 -0.0512 64 f{C6H7N2}/0.59ppm,p-H6N2
  111.0917494 22.4282 111.091965 1.8453 6.31 0.1675 70 f{C6H11N2}/0.67ppm,p-H2N2
  112.0869554 321.1610 112.087160 0.3479 13.11 0.9100 70 f{C5H10N3}/0.28ppm,p-C1H3N1
  113.0710464 19.1189 113.071240 2.1314 6.09 0.3526 70 ?
  113.0823765 20.2307 113.082570 2.1135 8.65 0.2774 70 f{C4H9N4}/1.80ppm,p-C2H4
  113.1074218 9.3228 113.107615 2.4402 3.22 -0.0896 60 f{C6H13N2}/0.86ppm,p-N2
  114.0664077 8.2223 114.066590 2.5336 2.66 0.3134 59 ?
  124.0869749 102.8938 124.087030 0.5561 35.42 -0.1050 70 f{C6H10N3}/0.41ppm,p-H3N1
  141.0662864 189.2994 141.066190 0.7302 63.58 0.2119 70 ?
  141.0860464 119.8454 141.085950 1.0207 33.60 0.4430 70 ?
  141.1025564 238.8770 141.102460 1.5875 61.70 0.1056 70 ?
  141.1138264 999.0000 141.113730 2.3315 0.00 1.0000 70 f{C6H13N4}/2.51ppm,p
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  58.065194 17.51 17
  69.044734 39.74 39
  70.041830 6.77 6
  70.048090 28.07 28
  70.065140 25.98 25
  71.060367 53.43 53
  72.044423 33.31 33
  73.047761 20.42 20
  85.076041 121.91 121
  95.060470 17.31 17
  97.076075 8.81 8
  98.071313 97.79 97
  100.075819 14.69 14
  107.060438 9.49 9
  111.091749 22.43 22
  112.086955 321.16 321
  113.071046 19.12 19
  113.082376 20.23 20
  113.107422 9.32 9
  114.066408 8.22 8
  124.086975 102.89 102
  141.066286 189.30 189
  141.086046 119.85 119
  141.102556 238.88 238
  141.113826 999.00 999
//
